Get the Stockscreener App
1.16
1.69%
-0.02
Apyx Medical Corp stock is traded at $1.16, with a volume of 43,745.
It is down -1.69% in the last 24 hours and up +28.89% over the past month.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
See More
Previous Close:
$1.18
Open:
$1.22
24h Volume:
43,745
Relative Volume:
0.90
Market Cap:
$47.24M
Revenue:
$52.35M
Net Income/Loss:
$-18.71M
P/E Ratio:
-2.1481
EPS:
-0.54
Net Cash Flow:
$-5.78M
1W Performance:
-7.20%
1M Performance:
+28.89%
6M Performance:
-23.68%
1Y Performance:
-30.12%
1-Day Range:
$1.12
$1.23
1-Week Range:
$1.04
$1.31
52-Week Range:
$0.7554
$1.99
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
(727) 384-2323
Address
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
1.16 | 47.24M | 52.35M | -18.71M | -5.78M | -0.54 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-24 | Initiated | BTIG Research | Neutral |
| Jul-14-23 | Initiated | Stephens | Overweight |
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
Apyx Medical Corp Stock (APYX) Latest News
Apyx Medical Corp SEC 10-Q Report - TradingView
SEC Form 10-Q filed by Apyx Medical Corporation - Quantisnow
Earnings call transcript: Apyx Medical beats Q1 2025 expectations, stock rises - Investing.com
Apyx Medical earnings beat by $0.02, revenue topped estimates - Investing.com
Apyx Medical Corporation Reports First Quarter 2025 Financial Results - The Manila Times
Apyx Medical Corp (APYX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence - Stock Titan
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence – Company Announcement - Financial Times
Apyx Medical (APYX) Highlighted in New Clinical Studies on Renuv - GuruFocus
Apyx Medical Co. (NASDAQ:APYX) Short Interest Update - Defense World
Apyx Medical Corporation Announces Two Peer-Reviewed - GlobeNewswire
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures - Yahoo Finance
Apyx Medical Corp. to Host Earnings Call - ACCESS Newswire
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025 - Quantisnow
Apyx Medical Sets Q1 Earnings Date: Latest Results Coming for Renuvion Plasma Technology Maker - Stock Titan
Reviewing Haemonetics (NYSE:HAE) and Apyx Medical (NASDAQ:APYX) - Defense World
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener" - Quantisnow
Apyx Medical’s SWOT analysis: helium-based plasma tech stock faces market headwinds - Investing.com
Apyx Medical (NASDAQ:APYX) & Bluejay Diagnostics (NASDAQ:BJDX) Head-To-Head Review - Defense World
Commonwealth Equity Services LLC Has $833,000 Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
Citizens JMP maintains Apyx Medical stock at Market Perform - Investing.com Australia
Reviewing Apyx Medical (NASDAQ:APYX) and PetVivo (NASDAQ:PETV) - Defense World
Liposuction Surgery Devices Market Growth Report and - GlobeNewswire
Liposuction Surgery Devices Market Growth Report and Company Analysis 2025-2033 Featuring SOLTA MEDICAL, InMode, Genesis Biosystems, Hologic, Apyx Medical, Cynosure, YOLO Medical, and Sciton - Yahoo Finance
APYX DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX - Business Wire
Apyx Medical Corporation (NASDAQ:APYX) Q4 2024 Earnings Call Transcript - Insider Monkey
Apyx Medical Corp (APYX) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Apyx Medical Reports 2024 Financial Results and Strategic Plans - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges - Investing.com Australia
Apyx Medical’s Mixed Earnings Call: Opportunities and Challenges - TipRanks
APYX stock touches 52-week low at $0.96 amid market challenges By Investing.com - Investing.com South Africa
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises By Investing.com - Investing.com South Africa
Apyx Medical reports Q4 EPS (12c), consensus (16c) - TipRanks
Earnings call transcript: Apyx Medical Q4 2024 beats EPS forecast, stock rises - Investing.com
Apyx Medical Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Apyx Medical earnings beat by $0.04, revenue topped estimates - Investing.com
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2024 Financial Results - The Manila Times
Earnings Scheduled For March 13, 2025 - Benzinga
Silver Wheaton, DocuSign, Ulta Beauty set to report earnings Thursday - Investing.com
Cosmetic Surgery Market Forecast Report and Company Analysis 2025-2033 Featuring AbbVie, Cutera, Sientra, Bausch Health, Johnson & Johnson, Apyx Medical, Hologic, Merz Pharma, Galderma, Cynosure - Yahoo Finance
Bioresorbable Polymers Market Grows with Innovations in Medical Devices - openPR
PSTV Rallies, TOVX Gears Up For VIRAGE Trial Data, Will AVTX's LOTUS Bloom? - RTTNews
Apyx Medical (APYX) Expected to Announce Quarterly Earnings on Thursday - Defense World
Tuesday's Afternoon Update - Florida Trend
Private Advisor Group LLC Has $491,000 Stock Holdings in Apyx Medical Co. (NASDAQ:APYX) - Defense World
The future of U.S. medical devices companies amid tariff impositions - MSN
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2024 Financial Results on March 13, 2025 - GlobeNewswire
Electrosurgical Devices Market Poised for Significant Growth | - openPR
Apyx Medical Corp Stock (APYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):